Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome by Bonelli, F. et al.
Plasma Procalcitonin Concentration in Healthy Horses and Horses
Aﬀected by Systemic Inﬂammatory Response Syndrome
F. Bonelli, V. Meucci, T.J. Divers, E. Jose-Cunilleras, M. Corazza, R. Tognetti, G. Guidi, L. Intorre, and
M. Sgorbini
Background: The diseases most frequent associated with SIRS in adult horses are those involving the gastrointestinal
tract. An early diagnosis should be the goal in the management of horses with SIRS.
Objective: The objective of this study was to evaluate the plasma procalcitonin (PCT) concentration in healthy and SIRS
horses to assess diﬀerences between the two groups.
Animals: Seventy-eight horses (30 healthy and 48 SIRS).
Methods: Prospective in vivo multicentric study. Horses were classiﬁed as SIRS if at least 2 of the following criteria were
met: abnormal leukocyte count or distribution, hyperthermia or hypothermia, tachycardia, tachypnea. Healthy horses showed
no clinical or laboratory signs of SIRS. Plasma PCT concentrations were measured with a commercial ELISA assay for
equine species. Results were expressed as meanstandard deviation. T-test for unpaired data was performed between healthy
and SIRS group. SIRS group was divided in 4 subgroups and t-test was performed between healthy versus each subgroup.
Results: PCT concentrations in healthy and SIRS horses were 18.28  20.32 and 197.0  117.0 pg/mL, respectively.
T-test showed statistical diﬀerences between healthy versus SIRS group and between healthy versus all subgroups.
Conclusions and Clinical Importance: Results showed an increase in PCT concentration in SIRS horses as previously
reported in humans and dogs. PCT could be used as a single assay in equine practice for detection of SIRS.
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Endotoxins (lipopolysaccharides, LPS) are present inlarge quantities in the large bowel of horses, but
are harmless as long as they remain within the intestinal
lumen. Equine gastrointestinal diseases involving hyper-
secretion of ﬂuid, motility disturbances, altered micro-
bial ﬂora, local stasis, ischemia, inﬂammation, and
impaired mucosal barrier may lead to absorption of
endotoxin, bacterial products or both through the
compromised mucosa into the bloodstream. Endotox-
emia induces release of acute phase proteins and cytoki-
nes that may result in severe organ dysfunction and
death.1 The physiologic changes associated with this
inﬂammatory activation are alteration in heart and res-
piratory rate, body temperature, mucous membrane sta-
tus, and capillary reﬁll time. Recently, some authors
have supposed that the term systemic inﬂammatory
response syndrome (SIRS), rather than endotoxemia,
should be used to describe the clinical status of “endo-
toxemic” horses. The diseases that have been associated
with SIRS in adult horses are especially those involving
the gastrointestinal tract, such as the inﬂammatory
intestinal diseases and strangulating obstructions.1 An
early diagnosis should be the goal in the management
of SIRS patients, allowing starting an adequate treat-
ment in an early stage.2,3 Due to the importance of pro-
calcitonin (PCT) as biomarker of SIRS in human
medicine,3 the aim of the present work was to evaluate
the plasma PCT concentration in healthy and SIRS
horses to evaluate the diﬀerences between the two
groups.
Materials and Methods
The present in vivo multicentric experimental trial in clinical set-
ting was approved by the Institutional Animal Care and Use Com-
mittee of the University of Pisa, University of Barcelona and Cornell
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University. A total of 78 horses were included in the present prospec-
tive study. Thirty were healthy horses from diﬀerent farms. Thir-
teen/30 (43%) were females, 11/30 (36%) geldings, and 6/30 (20%)
stallions. Mean age was 9.8  5.4 years old. Forty-eight were sick
horses referred to three diﬀerent veterinary teaching hospitals pro-
viding secondary health care. The following data were recorded both
for healthy and sick animals, in order to classify horses in healthy
and SIRS1 groups: presence of abnormal leukocyte count or distri-
bution as leukopenia, leukocytosis or >10% band neutrophils (refer-
ence intervals: 5.4–14.3 9 103 lL),4 hyperthermia or hypothermia
(reference intervals: 37.2–38.3°C),5 tachycardia (reference intervals:
28–44 bpm),5 tachypnea (reference intervals: 8–15 bpm).5 All the 30
healthy horses presented a normal physical examination and clinico-
pathologic data within reference ranges, thus they were included in
the control group. Horses with 2 or more criteria were included in
the SIRS group.1 Ten/48 (21%) sick horses were stallions, 18/48
(38%) geldings, and 20/48 (41.5%) females. Mean age was
10.3  6.7 years old. The horses were of diﬀerent breeds: Standard-
bred (n = 8), Pure Spanish Horse (n = 7), cross-breed (n = 6), Quar-
ter Horse (n = 6), Thoroughbred (n = 6), Ponies (n = 4), Italian
saddle horse (n = 3), Paint Horse (n = 3), Arabian (n = 1), Appa-
loosa Horse (n = 1), Belgian horse (n = 1), Hanoverian horse
(n = 1), and Warmblood (n = 1). An owner’s written consent was
obtained for collection of plasma for all the horses included in this
study. Retrospectively, SIRS horses were divided into 4 subgroups
based on nature of the pathological process: 18/48 (38%) strangu-
lated intestinal lesion, 13/48 (27%) nonstrangulated intestinal lesion,
11/48 (23%) diarrheas or colitis, and 6/48 (13%) pleuropneumonia.
All horses were submitted to a complete physical examination
and blood collection for CBC evaluation and plasma PCT analysis.
Blood samples for CBC and PCT concentrations were collected
from the jugular vein using a sterile syringe and 16G needle. Each
blood sample was divided in two aliquots: a 1 ml aliquot was col-
lected in a potassium ethylene diamine tetraacetic (K2EDTA) test
tube and analyzed by a cell countera within 5 minutes after the col-
lection. A second 2.5 mL aliquot was collected in heparinized-tubes
and immediately centrifuged at 2100 relative centrifugal force
(RCF) for 10 min. The harvested plasma was placed in sterile tubes,
frozen at 18°C and analyzed in a single batch within 3 months.
There was no intravenous administration of calcium before blood
collection, so as to not inﬂuence plasma PCT concentrations.
PCT concentrations were determined with a commercial kit for
equine species.b The intra-assay coeﬃcient of variation was deter-
mined from 10 replicates of equine plasma samples containing low
and high PCT concentrations. These samples were obtained by
addition of standard PCT in equine blank samples. The interassay
coeﬃcient of variation was determined from values obtained by
repeating the analysis of duplicate samples with low and high PCT
concentrations in 5 diﬀerent assays. To establish the detection limit
for equine plasma PCT, we performed repeated PCT measurements
using equine samples with low PCT concentrations (<10.0 pg/mL).
Samples were measured in 10 replicates in a single assay and in 5
diﬀerent assays. The intra- and interassay coeﬃcient of variations
were both <15%, the limit of detection of the method was 10 pg/ml.
Descriptive data are reported as mean  standard deviation.
Kolmogorov–Smirnov test was applied to verify data distribution.
T-test for unpaired data was performed to verify diﬀerences in
plasma PCT concentration between healthy versus SIRS group,
and between healthy versus each subgroup. Signiﬁcance level was
set at P < .05. A commercial statistical software was used.c
Results
All horses included in the healthy group showed no
clinical and clinico-pathologic signs of SIRS, while all
the 48 sick horses presented 2 or more signs of SIRS.
The plasma PCT concentration was
18.28  20.32 pg/mL and 197.0  117.0 pg/mL in
healthy and SIRS group, respectively, while plasma
PCT concentrations in various subgroups were reported
in Table 1. T-test for unpaired data showed a statistical
diﬀerence between healthy versus SIRS group and
between healthy versus all subgroups.
Discussion
PCT appears to be an early marker of SIRS caused
by bacterial infections and associated products in
human medicine.3,6 PCT originates from the CALC-I
gene transcription and calcitonin-mRNA translation. In
healthy patients, the transcription of the CALC-I gene
is restricted to neuroendocrine cells in the thyroid gland
and the lung and healthy individuals have very low
serum concentrations.3,6 During a state of infection the
expression of the CALC-I gene is up regulated and
PCT is released from many tissues and cell types in the
body in laboratory animals, dogs and horses, as well as
in human patients.3,6–8 Moreover, plasma PCT concen-
tration rises rapidly within 3-6 h, especially in response
to bacterial infection and endotoxemia, seeming to be
also an early marker of bacterial infection and endotox-
emia in human patients.3,6
Plasma PCT concentration was lower in healthy
horses than in SIRS ones. Our results are in line with
earlier studies performed in equine, canine, and human
species.3,6,9–11 The mean plasma PCT concentration
reported in this study, both for healthy and SIRS
group, were lower than those reported in another study
performed in 29 horses (24 healthy horses and 5 septic
horses).10 The dissimilarity might be due to the diﬀerent
PCT ELISA kit used: in our study, an equine PCT
ELISA kit assay for PCT determination was used, while
Rieger and colleagues (2014)10 have used an ELISA
assay in which, human antibodies were directed against
equine PCT. Plasma PCT levels were similar to those
reported in foals and plasmatic PCT concentrations
were statistically diﬀerent between healthy versus SIRS
groups both in foals and in adults, conﬁrming that PCT
increases during SIRS.11
PCT levels in horses in this study were generally
lower than levels reported in humans with SIRS.3,6 This
dissimilarity might be related to the diﬀerent species
studied, less severe inﬂammation in the studied horses,
or possibly endotoxin tolerance.12 Moreover, Yilmaz
and colleagues (2008)9 evaluated the changes in PCT
concentrations in dogs after administration of
endotoxin, which resulted lower than our results. This
Table 1. Plasmatic PCT concentrations, expressed as
mean  SD, obtained in the 4 subgroups
Disease
PCT (pg/mL)
(X  SD)
P versus
healthy group
Strangulated intestinal lesion 232  155 <0.0001
Nonstrangulated intestinal lesion 148  79 <0.0001
Diarrhea or Colitis 168  91 <0.0001
Pleuropneumonia 217  95 <0.0001
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diﬀerence could be related to the species studied (dog
versus horse) and to the diﬀerent assay used.
PCT concentrations obtained in all subgroups
resulted statistically higher than the healthy group, con-
ﬁrming that plasmatic PCT levels increase during SIRS
process. No statistically diﬀerences were found between
subgroups; this ﬁnding might be due to the small num-
ber of animals included in the subgroups.
PCT seems to be a sensitive and speciﬁc marker of
SIRS in horses. The limit of the study might be the
number of cases included (n = 48). An increased study
population is needed to investigate the role of PCT in
being able to distinguish between septic and nonseptic
SIRS in adult horses and to shortening antimicrobial
treatment as already reported in humans.3,6
Footnotes
a ProCyte DxTM; IDEXX, USA
b Horse Procalcitonin ELISA kit; MyBiosource.com
c Graph Pad Prism 6, USA
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